Header Logo

Connection

Naoko Takebe to Liver Neoplasms

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Liver Neoplasms.
Naoko Takebe
Connection Strength
0.197
Liver Neoplasms
  1. Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort. Invest New Drugs. 2024 Feb; 42(1):127-135.
    View in: PubMed
    Score: 0.197
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.